dx 9065 has been researched along with benzamidine in 2 studies
*benzamidine: RN given refers to parent cpd [MeSH]
*benzamidine: RN given refers to parent cpd [MeSH]
| Studies (dx 9065) | Trials (dx 9065) | Recent Studies (post-2010) (dx 9065) | Studies (benzamidine) | Trials (benzamidine) | Recent Studies (post-2010) (benzamidine) |
|---|---|---|---|---|---|
| 17 | 0 | 0 | 291 | 2 | 77 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cruciani, G; Fox, T; Haaksma, EE; Kastenholz, MA; Pastor, M | 1 |
| Brady, L; Jones, SD; Liebeschuetz, JW; Mahler, J; Martin, H; Morgan, PJ; Murray, CW; Rimmer, AD; Roscoe, JM; Waszkowycz, B; Welsh, PM; Wilkinson, K; Wylie, WA; Young, SC | 1 |
2 other study(ies) available for dx 9065 and benzamidine
| Article | Year |
|---|---|
GRID/CPCA: a new computational tool to design selective ligands.
Topics: Algorithms; Binding Sites; Drug Design; Factor Xa; Ligands; Models, Molecular; Structure-Activity Relationship; Thrombin; Trypsin | 2000 |
PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors.
Topics: Animals; Benzamidines; Combinatorial Chemistry Techniques; Drug Design; Enzyme Inhibitors; Factor Xa Inhibitors; Humans; Models, Molecular; Protein Conformation; Rats; Structure-Activity Relationship | 2002 |